Our findings suggest that even though chemotherapy could not prevent osteosarcoma growth in chemotherapy poor responders, chemotherapy prevents osteosarcoma cell migration into blood vessel by down-regulation of urokinase plasminogen activation via up-regulation of EGR1 during chemotherapy periods. The gene discussed is EGR1; the disease is osteosarcoma.